Objective: The objective was to evaluate the postneonatal mortality rate at our institution from 1999 to 2006 as a follow-up to a previous report from our hospital covering 1993 to 1998 and to investigate the causes of death in infants dying in the postneonatal period.
Introduction
The infant mortality rate, often regarded as an indicator of population health, has been rigorously studied since the 1970s. Since that time, technological, pharmacological and biochemical advances, in addition to medical interest in the care of infants, have resulted in a decrease in the infant mortality rate over the last several decades. 1 As these advances occurred and the trends were followed, investigators nationwide became concerned about the postneonatal mortality rate (PMR). 2 It was observed in the very low birth weight (VLBW) and extremely low birth weight groups that while infant mortality and specifically neonatal mortality declined, postneonatal mortality either failed to decline at an equal rate or even increased. A study of neonatal deaths in Massachusetts compared the postneonatal death rates from 1970 to 1972 with those from 1978 to 1980. 3 They observed that there was no decline in the PMR for infants under 2500 g and that there was an increase in the rate for infants weighing 401 to 1000 g. Another study from Tennessee showed a six-fold increase in postneonatal mortality associated with prematurity-related causes in VLBW infants in the years 1984 to 1988, as compared to the previous 5 years. 4 A nationwide study reported similar findings for the VLBW infants, namely that for infants under 1000 g there was an increase, and for those under 1500 g, there was no decline. 5 It became clear that deaths from the neonatal period were being postponed into the postneonatal period. This translated into a grave concern over the potential pain and suffering endured by these infants. The emotional stress placed upon the infants' families and caregivers also seemed needless. In addition, questions were raised about financing this costly, intensive and prolonged care. However, even though these postponed deaths were, and still are, a major concern, few studies have looked at postneonatal mortality or its causes and prevention. Therefore, our institution, Los Angeles County þ University of Southern California (LAC þ USC) Medical Center, has followed the postneonatal infant mortality rates since 1993 with the goal of understanding these deaths and their causes. 1 In the review covering 1993 to 1998, a PMR of 12% was reported. Unfortunately, we were unable to find consistent features that would reliably identify infants, who would later die in the postneonatal period. In the light of continuing decreases in mortality rates, we wanted to again survey the causes of postneonatal deaths and evaluate the mortality rate for any changes.
Methods
We conducted a retrospective study of inborn infants at the LAC þ USC Medical Center from 1999 to 2006 using a neonatal database, Neonatal Information System-III, (NIS-III), from Medical Data Systems. We identified all infant deaths before discharge from the nursery of infants aged X28 days. Clinical data for all cases including maternal and perinatal history, birth weight, Apgar scores, treatment and complications, length of stay and autopsy records when performed were reviewed and a cause of death was determined for each infant.
We excluded infants transferred to our neonatal intensive care nursery from outside hospitals if these infants were admitted >6 h after birth so that our data would reflect perinatal mortality at our institution. We are not a large neonatal referral center and of the few infants who were transferred in, most were sent for patent ductus arteriosus surgery, laser eye surgery, or for other chronic conditions. Of the few transferred in infants who died later, most were admitted >1st day of life, and many were not transferred in until several months of age. We also excluded infants who were discharged home from the Neonatal Intensive Care Unit (NICU) of the hospital and later readmitted to the NICU. These infants were excluded, because the only readmissions to the NICU were readmitted for laser eye surgery and none of these readmitted infants expired. We included inborn infants, who were transferred to outside facilities for specialty or long-term care and who subsequently expired. However, we do not include infants who died >1 year of age at outside facilities. It is important to note that the previous study at our institution had the same inclusion criteria. 1 In the calculation of overall infant mortality at our institution infant deaths in the delivery room were included in the total sum. P-values were calculated using a two-sample test for binomial proportions.
The score for neonatal acute physiology (SNAP) and SNAP physiologic extension (SNAP-PE) for neonates weighing 500 to 1250 g from our study group were compared with 232 survivors taken from the same period (1999 to 2006).
Our institution serves a predominantly Hispanic population (94%), with the majority of the patients being of Mexican heritage. Permission to collect data for this project was approved by the Institutional Review board of the LAC þ USC Medical Center. The data was collected as part of normal quality improvement efforts at LAC þ USC, and therefore parental permission was not needed.
Results
From 1999 to 2006, there were 13 967 live births at LAC þ USC, and of these, there were 211 deaths (1.51%). Fourteen (6.6%) of these deaths occurred after the neonatal period ( Table 1) . The PMR of 6.6% represents a decreasing trend from the 12% reported in 1993 to 1998 (P-value ¼ 0.064). 1 Of the 14 infants, we determined that five died as a result of the complications of prematurity. Of these five, all had chronic lung disease, four had abdominal surgery for necrotizing enterocolitis, one had positive peritoneal cultures within the last 2 weeks of life, and two had intraventricular hemorrhage (IVH) of grade IV. All of these infants had multiple organ failure by the time of death and the final event was infection and/or renal failure.
The nine infants with congenital anomalies represent a heterogeneous group including two with trisomy 21 with complications and one with CHARGE syndrome (coloboma of the eye, heart anomaly, choanal atresia, mental and growth retardation, genital anomaly, and ear anomaly). Three had heart defects including a hypertrophic cardiomyopathy (Pompe's disease), one with multiple heart defects (atrioventricular canal defect, atrioventricular block, subaortic stenosis, and interrupted inferior vena cava), and the last with Tetralogy of fallot and total anomalous pulmonary venous return, as well as esophageal atresia and tracheoesophageal fistula. Of the remaining three infants, one had hydranencephaly, one had caudal regression, malrotation and intussusception as well as atrial and ventricular septal defects and the final infant had multiple vascular liver tumors (hemangioendotheliomas).
The mean SNAP was 9.6 and 9.7 for postneonatal deaths and survivors respectively. The mean SNAP-PE was 34.6 for postneonatal deaths and 29 for survivors. There was no statistically significant difference between these two groups.
The mean birth weight of infants in the postponed neonatal death group in the previous study was 617 g. 1 In the comparable group of infants in this study (complications of prematurity), the mean weight was 830 g (P<0.001).
In our previous study, only 29% of the infants who died postneonatally received antenatal steroids. 1 In this study, 100% of the infants in the complications of prematurity group received at least some antenatal steroids. 
Discussion
The PMR of 6.6% represents a decreasing trend from the 12% reported in 1993 to 1998. 1 While our results are not statistically significant, they are trending toward significance and the possibility of this decrease is worth exploring further.
Like our previous study, the causes of deaths divided into two groups, congenital defects and complications of prematurity. This is consistent with national data, which shows that the two major causes of infant mortality are congenital malformations, including deformations and chromosomal abnormalities, and disorders related to short gestation and low birth weight. 2 It should be noted that, in 2004, there was a statistically significant decrease of 4.8% in the percentage of deaths attributable to low birth weight/short gestation. In our study, we found that 64% of postneonatal deaths were due to congenital anomalies versus 35% for complications of prematurity. In the previous study, the groups split fairly equally into 52 versus 48%, for congenital anomalies and postponed neonatal deaths, respectively. However, this difference is not statistically significant (P ¼ 0.329).
As with our previous study, we were unable to find a consistent means of individually identifying infants, who would die postneonatally. SNAP and SNAP-PE scores, a factor that we did not look at in our previous study but chose to examine in this study, failed to distinguish such infants. This illness severity score, however, has its limitations in prognostication, as it only considers the first 12 to 24 h of life. While it is clear that the infants who died were sicker than their peers who survived, there was no other distinguishing characteristic that would allow these infants to be identified earlier in the neonatal period.
The importance of the decreasing trend in postneonatal mortality remains to be explored. One interesting possibility is that there has been a response to the concerns of the postponement of neonatal death leading to earlier withdrawal of care. At many institutions, including ours, the practices and policies of withholding and withdrawing care have been studied and modified. [6] [7] [8] [9] [10] At LAC þ USC, 72% of deaths from 1993 to 2002 resulted from care not initiated or care withdrawn. 6 We believe that such intense interest with respect to infant quality of life has resulted in fewer postponed deaths in the postneonatal period.
This change in philosophy is reflected in a 1999 policy change at LAC þ USC. Previous to that year, decisions regarding resuscitation of infants at birth took into consideration the great improvements in neonatal intensive care and the declining neonatal mortality rate. The policy was to resuscitate infants of 450 g or more and of at least 23 weeks gestation. In 1999, the emphasis in decision making shifted to concerns of complications and long-term morbidity in these VLBW infants after a very poor 2-year outcome in these infants was observed. 11 It was then decided that there would be no routine resuscitation for infants <500 g or <23 weeks gestation. Infants of 500-600 g or >23 1/7th to 23 6/7th weeks gestation are resuscitated at the parents' request. Routine resuscitation is performed on infants >601 g or X24 weeks gestational age. This policy change, occurring in 1999, the first year of this study, could, at least in part, account for the declining trend in PMR that we observed in the subsequent 8 years. This assumption is supported by the statistically significant difference in the mean birth weight of infants in the postponed neonatal death groups of each study (with infants in the current study weighing B200 g more on average than their counterparts). 1 The resuscitation of extremely premature infants at the edge of viability no doubt resulted in very ill infants, some of whom would have died rather shortly after resuscitation, some of whom would live with poor developmental outcomes, and likely a few, who would have a protracted course of illness ending in death in the postneonatal period.
It is interesting to consider that perhaps withholding care is being considered differently for the two groups of infants (congenital anomalies vs complications of prematurity). The infants with congenital anomalies, the majority of whom are sent to Children's Hospital Los Angeles for extensive corrective surgeries, often receive full resuscitative efforts and total care as it is hoped that surgery will be successful. Indeed, it was shown that while extreme prematurity made up 60% of cases in which care was not initiated at birth, congenital anomalies only made up 33% of the cases. 6 This may account for the increasing percentage of postneonatal deaths made up by congenital anomalies.
Another aspect to consider as important to decreasing the PMR is the improved early management of premature infants and ventilating procedures. While surfactant has been available since the FDA approval in 1990 of Exosurf, and while it has been known for some time that replacement decreases neonatal mortality rate, the optimal timing of surfactant administration has only been recently emphasized. A Cochrane meta-analysis performed by Yost et al.
12
, suggests that infants receiving surfactant within the first 2 h of life have a reduced risk of pneumothorax, pulmonary interstitial emphysema, chronic lung disease and mortality. At our institution, we attempt to give surfactant to VLBW infants before 30 min of life, and at the latest, it is given by 1 h of age. This change in neonatal care could also have been a major factor in the decreasing PMR.
Ventilator procedures have also been modified with an emphasis on less aggressive care by using low pressures during mechanical ventilation. 13 It has also been shown that while the use of noninvasive ventilatory support has increased, the rates of chronic lung disease and neonatal mortality have declined.
14 These noninvasive techniques, such as continuous positive airway pressure and nasal cannula with high pressure, are being extensively used at our institution. As the duration of ventilator support is associated with an increased risk of developing chronic lung disease, timely weaning of ventilator support is also crucial for reducing chronic lung disease.
14 Taken together, these changes in the respiratory care of the neonate have resulted in decreased chronic lung disease, fewer complications, and decreased mortality at our institution and at other institutions nationwide. Finally, the use of antenatal steroids also merits mention. It has been found that antenatal steroids decrease the severity of respiratory distress syndrome, necrotizing enterocolitis, patent ductus arteriosus, and IVH. 13, 15 Our data indicate that antenatal steroids were given consistently to mothers in preterm labor. The only infants whose mothers did not receive an entire course of antenatal steroids were in fetal distress at the time of birth and were delivered via emergency cesarean section. This represents a response to the previous study from our institution showing a statistically significant difference in antenatal steroid use among mothers of survivors. 1 We believe that the more consistent use of antenatal steroids has contributed to the declining trend in postneonatal mortality at LAC þ USC.
Indeed, the advances at this institution in the early management of premature neonates have resulted in increased survival. In 2004 to 2005, we had a 100% survival rate of infants without congenital anomalies weighing above 600 g. It is likely that this increased survival is the major contributor to the decreasing trend in PMR that we observe. However, we still have a dismal survival rate (30 to 40%) in the infants weighing 500 to 599 g. Likewise, there has been little change in the PMR in the congenital anomalies group.
However, it is important to note that while we have had an increase in survival, we also have had an increase in our neonatal mortality rate during the years of this study. While in the previous study we had 39 666 live births and 220 neonatal deaths, in this study we had only 13 967 live births and 197 neonatal deaths. 1 Over the years of 1993 to 1998, the neonatal mortality rate for all birth weights ranged between 4.7 and 9.6%. From 1999 to 2006, the neonatal mortality rate ranged from 8.6 to 20.1%. Our center has seen a marked decrease in the total number of deliveries, especially normal pregnancies, while the number of high-risk deliveries remains essentially unchanged. This is reflected in our much higher neonatal mortality rate and this may indeed have an impact on a decreasing PMR.
It is our belief that further decreases in postneonatal and neonatal mortality will arise from the prevention of prematurity and congenital anomalies. Research into the causes and prevention of congenital anomalies and prematurity will be of crucial importance to further decrease the postneonatal mortality rate.
